Cargando…
Intensive Chemotherapy Is Associated With Poor Overall Survival in Autoimmune Disease-associated Myeloid Malignancies
Autores principales: | Richardson, Simon E., Brian, Duncan, Grandage, Victoria, Hough, Rachael, Kottaridis, Panagiotis, Mansour, Marc R., Payne, Elspeth M., Khwaja, Asim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745931/ https://www.ncbi.nlm.nih.gov/pubmed/31723803 http://dx.doi.org/10.1097/HS9.0000000000000164 |
Ejemplares similares
-
Gilteritinib monotherapy as a transplant bridging option for high risk FLT3-mutated AML with t(6;9)(p23;q34.1);DEK-NUP214 in morphological but not cytogenetic or molecular remission following standard induction chemotherapy
por: Day, James W, et al.
Publicado: (2022) -
Wilms’ Tumour 1 (WT1) peptide vaccination in patients with acute myeloid leukaemia induces short-lived WT1-specific immune responses
por: Uttenthal, Benjamin, et al.
Publicado: (2014) -
Higher TOX Genes Expression Is Associated With Poor Overall Survival for Patients With Acute Myeloid Leukemia
por: Liang, Chaofeng, et al.
Publicado: (2021) -
P413: GENOMIC AND TRANSCRIPTOMIC ANALYSES OF NORMAL KARYOTYPE PRIMARY REFRACTORY ACUTE MYELOID LEUKAEMIA REVEAL HIGH INCIDENCE OF WT1 MUTATIONS AND A TRANSCRIPTIONAL SIGNATURE OF SENESCENCE.
por: Alhawaj, Ali, et al.
Publicado: (2023) -
Increased PD-1(+)Foxp3(+) γδ T cells associate with poor overall survival for patients with acute myeloid leukemia
por: Zheng, Jiamian, et al.
Publicado: (2022)